First Time Loading...

Australian Clinical Labs Ltd
ASX:ACL

Watchlist Manager
Australian Clinical Labs Ltd Logo
Australian Clinical Labs Ltd
ASX:ACL
Watchlist
Price: 2.44 AUD 1.24% Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

There is not enough data to reliably calculate the relative value of ACL.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACL Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

0.7
P/S
P/S
Price to Sales
0.7
vs History
89
vs Industry
74
Median 3Y
0.9
Median 5Y
0.9
Industry
2.4
Forward
0.7
More Details
13.6
P/E
P/E
Price to Earnings
13.6
vs History
28
vs Industry
36
Median 3Y
9.8
Median 5Y
9.8
Industry
23.4
Forward
11
More Details
3.4
P/OCF
P/OCF
Price to OCF
3.4
vs History
76
vs Industry
50
Median 3Y
4
Median 5Y
4
Industry
15.5
More Details
4.6
P/FCFE
P/FCFE
Price to FCFE
4.6
vs History
76
vs Industry
39
Median 3Y
5.6
Median 5Y
5.6
Industry
23.2
More Details
2.8
P/B
P/B
Price to Book Value
2.8
vs History
92
vs Industry
31
Median 3Y
3.6
Median 5Y
3.6
Industry
2.3
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
81
vs Industry
68
Median 3Y
1.1
Median 5Y
1.1
Industry
2.5
Forward
1
More Details
1.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.2
vs History
84
vs Industry
79
Median 3Y
1.4
Median 5Y
1.4
Industry
5.3
More Details
10.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.5
vs History
28
vs Industry
32
Median 3Y
7.2
Median 5Y
7.2
Industry
12.6
Forward
3.4
More Details
10.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
10.5
vs History
28
vs Industry
38
Median 3Y
7.2
Median 5Y
7.2
Industry
17.2
Forward
9.8
More Details
4.7
EV/OCF
EV/OCF
Enterprise Value to OCF
4.7
vs History
68
vs Industry
48
Median 3Y
5
Median 5Y
5
Industry
15.3
More Details
5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
5
vs History
71
vs Industry
40
Median 3Y
5.3
Median 5Y
5.3
Industry
19.8
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
94
vs Industry
52
Median 3Y
1.7
Median 5Y
1.7
Industry
2
More Details

Multiples Across Competitors

ACL Competitors Multiples
Australian Clinical Labs Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Australian Clinical Labs Ltd
ASX:ACL
489.2m AUD 0.7 13.6 10.5 10.5
US
Cigna Group
XMUN:CGN
94.9B EUR 0.5 19.8 10.2 13.6
US
Cigna Corp
NYSE:CI
99.9B USD 0.5 19.3 10 13.3
US
CVS Health Corp
NYSE:CVS
70B USD 0.2 9.6 8.7 8.7
US
Laboratory Corporation of America Holdings
NYSE:LH
17B USD 1.4 39.2 11.9 18
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.7B EUR 0.7 -26.5 10.1 22.6
US
Quest Diagnostics Inc
NYSE:DGX
15.2B USD 1.6 18.1 10.8 14.6
DE
Fresenius Medical Care AG
XMUN:FME
11.9B EUR 0.6 23.9 7 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.5B EUR 0.6 23.1 6.9 16.3
US
DaVita Inc
NYSE:DVA
11.9B USD 1 17.3 8.4 12.4
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
ACL intrinsic value, competitors valuation, and company profile.
DCF Valuation
ACL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ACL stock valuation using valuation multiples.
Wall Street Estimates
ACL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ACL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.